Sepsis remains one of the most urgent but often overlooked global health challenges. Despite advances in healthcare, sepsis continues to cause millions of deaths each year worldwide. As global health agencies and policymakers push for stronger action, innovations in diagnostics are reshaping how we approach this complex condition.
Sepsis Incidence and Mortality Rates
The World Health Organization (WHO) estimates that sepsis affects 49 million people annually, leading to 11 million deaths—roughly 1 in 5 deaths worldwide each year. [1] Sepsis disproportionately impacts vulnerable populations, including newborns, pregnant women, the elderly, and people living in low- and middle-income countries.
In high-income countries, sepsis contributes significantly to healthcare costs and hospital mortality, but in resource-limited settings, the burden is magnified due to limited access to early diagnostics and treatment.
WHO’s Position and Action Plans
In 2017, the World Health Assembly passed a landmark resolution on sepsis, calling on member states to improve prevention, diagnosis, and management. [2] The WHO continues to emphasize sepsis as a global health priority, urging nations to integrate sepsis awareness, training, and diagnostic tools into existing health programs.
Key WHO recommendations include:
- Strengthening surveillance systems to better understand sepsis burden.
- Improving early recognition and clinical response.
- Investing in affordable, accessible diagnostics.
Regional Differences in Sepsis Burden
The burden of sepsis is not evenly distributed across the globe, and regional differences highlight both healthcare disparities and opportunities for improvement.
Africa: High rates of maternal and neonatal sepsis remain a major concern, often tied to limited access to timely care and antibiotics. [3]
Asia-Pacific (APAC): The Asia-Pacific region carries a disproportionately high burden of sepsis. Depending on the country, incidence ranges from 120 to 1,600 cases per 100,000 population, with mortality rates reaching up to 35% in some areas.[4] This reflects the region’s large populations and uneven healthcare infrastructure.
Europe: Across European ICUs, patients with sepsis show average ICU mortality of ~25.8% and hospital mortality of ~35.3%. Rates vary widely across countries, underscoring the need for improved early detection and standardized care pathways.[5]
North America vs. Europe: Comparative studies suggest that raw hospital mortality is substantially higher in Europe compared to the United States. For instance, one large study reported mortality rates of ~28.3% in the US versus ~41.1% in Europe for severe sepsis and septic shock cohorts.[6]
The Role of Innovation and Diagnostics
One of the critical barriers in sepsis care is time to diagnosis. Traditional blood cultures can take up to several days to confirm the causative pathogen. During this time, clinicians often rely on empirical broad-spectrum antibiotics, which can lead to overtreatment and antimicrobial resistance.
Molecular diagnostics, capable of identifying pathogens directly from blood within hours, are transforming this landscape. By reducing delays in diagnosis, such tools enable earlier, potentially targeted treatment and improved patient outcomes—particularly crucial in regions where healthcare resources are limited.
Microbio’s Global Mission
At Microbio, we are committed to addressing this global health threat. Our InfectID™-BSI molecular assay is designed to directly detect 26 sepsis-associated bacterial and yeast pathogens from blood samples in three hours.
By providing clinicians worldwide with faster, more accurate diagnostic tools, we aim to support earlier intervention, reduce reliance on broad-spectrum antibiotics, and help lower the global burden of sepsis.
References- World Health Organization. Sepsis. Updated 2023. https://www.who.int/news-room/fact-sheets/detail/sepsis.[↩]
- World Health Assembly. Resolution WHA70.7: Improving the prevention, diagnosis and clinical management of sepsis. 2017.[↩]
- Rudd KE, et al. Global, regional, and national sepsis incidence and mortality, 1990–2017: analysis for the Global Burden of Disease Study. Lancet. 2020;395(10219):200–211.[↩]
- Asia Pacific Sepsis Alliance. Sepsis burden in the Asia Pacific. https://www.asiapacificsepsisalliance.org/sepsis[↩]
- Vincent J-L, Marshall JC, Ñamendys-Silva SA, et al. Assessment of the worldwide burden of critical illness: the Intensive Care Over Nations (ICON) audit. Lancet Respir Med. 2014;2(5):380–386.[↩]
- Vincent J-L, Sakr Y, Sprung CL, et al. Sepsis in European vs. North American intensive care units: results of the SOAP study. Lancet Infect Dis. 2006;6(5):330–33[↩]